Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-12

Clinical Trial Update: Safety and Efficacy of APD356 in the Treatment of Obesity [Phase 2]

View source ↗

Summary

Phase 2 trial update on APD356 for obesity reports safety and efficacy data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • APD356

Snippet

Sponsor: Eisai Inc. | Conditions: Obesity | Phase 2 | Status: COMPLETED